AZTA Logo

Azenta, Inc. (AZTA) 

NASDAQ
Market Cap
$2.23B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
98 of 775
Rank in Industry
5 of 48

Largest Insider Buys in Sector

AZTA Stock Price History Chart

AZTA Stock Performance

About Azenta, Inc.

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their …

Insider Activity of Azenta, Inc.

Over the last 12 months, insiders at Azenta, Inc. have bought $1.29M and sold $205,948 worth of Azenta, Inc. stock.

On average, over the past 5 years, insiders at Azenta, Inc. have bought $1.02M and sold $10.52M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Madaus Martin D (director) — $805,615. Marotta John (President and CEO) — $552,904. Cornog William L (director) — $495,000.

The last purchase of 4,940 shares for transaction amount of $201,404 was made by Madaus Martin D (director) on 2024‑11‑19.

List of Insider Buy and Sell Transactions, Azenta, Inc.

2024-11-19SaleSVP, General Counsel, Secy.
1,139
0.0023%
$40.07$45,6400.00%
2024-11-19SaleSVP and General Manager, Genom
491
0.001%
$40.07$19,6740.00%
2024-11-19SaleSVP & GM, SMS
348
0.0007%
$40.07$13,9440.00%
2024-11-19SaleEVP, Chief Financial Officer
712
0.0014%
$40.07$28,5300.00%
2024-11-19SaleSVP and CHRO
548
0.0011%
$40.07$21,9580.00%
2024-11-19SaleVP, Chief Accounting Officer
163
0.0003%
$40.07$6,5310.00%
2024-11-19PurchasePresident and CEO
1,250
0.0026%
$40.67$50,8380.00%
2024-11-19Purchasedirector
4,940
0.0101%
$40.77$201,404-0.25%
2024-11-18PurchasePresident and CEO
12,716.98
0.0254%
$39.48$502,066+3.01%
2024-11-18Purchasedirector
12,500
0.0251%
$39.60$495,000+2.70%
2024-11-18Purchasedirector
1,000
0.002%
$39.50$39,500+2.96%
2024-10-17SaleEVP, Chief Financial Officer
1,595
0.0033%
$43.68$69,670+2.46%
2023-08-11SaleChief Strategy & New Business
10,877
0.0166%
$56.03$609,438-0.58%
2023-08-10SaleChief Strategy & New Business
10,732
0.017%
$57.24$614,300+0.32%
2023-06-06Saledirector
2,400
0.0033%
$43.07$103,368+19.66%
2022-08-19PurchaseEVP & Chief Financial Officer
4,350
0.0058%
$57.62$250,647-20.56%
2022-08-19PurchaseEVP & Chief Operating Officer
8,625
0.0116%
$58.15$501,544-20.56%
2022-04-12SaleSVP, Chief HR Officer
132
0.0002%
$78.02$10,299-25.53%
2022-01-04SaleChief Commercial Officer, LS
191
0.0003%
$102.59$19,595-32.86%
2021-11-19SalePresident, Semi Solutions
10,216
0.0138%
$120.29$1.23M-37.27%

Insider Historical Profitability

13.89%
Marotta JohnPresident and CEO
100862
0.2062%
$45.5020
Cornog William Ldirector
14755
0.0302%
$45.5010
Madaus Martin Ddirector
7405
0.0151%
$45.5010
HIRSCH DIDIERdirector
3465
0.0071%
$45.5010
Robertson Lindon GEVP & Chief Financial Officer
100571
0.2056%
$45.50220+14.96%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$322.53M9.925.35M-5.3%-$18.05M0.01
KAYNE ANDERSON INVESTMENT MANAGEMENT LLC$313.29M9.645.2M+12.41%+$34.59M0.73
BlackRock$306.37M9.435.08M-6.97%-$22.94M0.01
Politan Capital Management Lp$278M8.554.61M+0.74%+$2.03M14.46
Dimensional Fund Advisors$153.67M4.732.55M+14.22%+$19.14M0.04
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.